| Code | 44056 | ||||||||||
| MA number | 44/0289/00-S | ||||||||||
| Product Form: | tbl 30x10 mg (liek.PP) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 02.08.2000 |
| Pediatric warnings: | Yes |
| SPC: |
SPC_TAMOXIFEN Sandoz 10 mg_12.2021.pdf
|
| PIL: |
PIL_TAMOXIFEN Sandoz 10 mg_12.2021.pdf
|
| Safety feature | Yes |
| Data update: | 23.03.2021 |
